Dabaz 200 Injection contains Dacarbazine, a chemotherapy medication commonly used to treat certain types of cancer, such as Hodgkin's lymphoma and malignant melanoma. 

Brand Name: Dabaz

Composition: Dacarbazine

Mechanism of Action:

Dacarbazine is categorized as an alkylating agent and is cytotoxic. In the liver, it is metabolically activated to produce methylating species that bind with DNA. This results in the suppression of transcription and DNA replication, which ultimately kills rapidly proliferating cancer cells.

Uses:

• Hodgkin's Lymphoma
• Metastatic Malignant Melanoma

Dosage and Administration:

Administered intravenously. The illness, body surface area, and treatment plan all affect dosage. To allow for recovery in between doses, it is usually administered in cycles.

Side Effects:

• Nausea
• Vomiting
• Fever
• Chill
• Dizziness
• Diarrhea
• Fatigue
• Injection site reactions (pain, redness, irritation)

Safety Advise:

Lungs  

The safety of Dabaz Injection for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Liver  

The safety of Dabaz Injection for individuals with liver issues is uncertain. Kindly speak with your healthcare provider.

Kidney  

The safety of Dabaz Injection for individuals with Kidney issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Dabaz should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Dabaz while nursing is most likely dangerous. Kindly speak with your healthcare provider. 

Storage:

Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light and use immediately after reconstitution.

How to use this Medication?

Dacarbazine injection is available as a powder that can be combined with liquid and administered intravenously (into a vein) over a period of one minute or intravenously over a period of fifteen to thirty minutes by a medical professional. Dacarbazine can be administered once daily for 10 consecutive days every 4 weeks or once daily for 5 consecutive days every 3 weeks to treat melanoma. Dacarbazine can be administered once daily for five consecutive days every four weeks or once every fifteen days to treat Hodgkin's lymphoma.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.